Trials / Completed
CompletedNCT02761837
The Breathe Well Program for Adults With Asthma
The Breathe Well Program to Improve Asthma Outcomes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14,978 (actual)
- Sponsor
- National Jewish Health · Academic / Other
- Sex
- All
- Age
- 19 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The Breathe Well Study is a pragmatic, controlled trial to assess the effectiveness, cost-effectiveness, and implementation of the Breathe Well intervention, which combines evidence-based EHR and interactive behavior-change technologies (IBCT) and team-based care to improve asthma outcomes.
Detailed description
Breathe Well uses the Kaiser Permanente Electronic Health Record (EHR) to identify asthma exacerbation risk factors. For patients with a history of frequent exacerbations or B-agonist overuse, the EHR notifies a nurse who uses an EHR-generated tailored clinical report and patient directed decision support tool to engage and empower patients to develop an action plan in collaboration with providers. EHR-templated notes and order sets facilitate care plan execution. Poor controller medication adherence or unaddressed smoking results in the patient being automatically enrolled in an IBCT medication refill or smoking cessation program. Breathe Well uses multiple EHR functions and a patient and provider team to address barriers to evidence-based asthma care for providers.The study will be conducted in 26 primary care clinics of Kaiser Permanente Colorado (KPCO) using a pragmatic clinical trial design. Up to 15,000 high-risk asthma patients will be assigned to Breathe Well or guideline-based usual care based on their clinic.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | IVR call/text | For patients under filling their inhaled corticosteroid or overusing B-agonist, the patient is contacted via IVR call or text |
| BEHAVIORAL | Patients under filling their inhaled corticosteroid or overusing B-agonist, the the patient is contacted via email |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2016-05-04
- Last updated
- 2023-11-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02761837. Inclusion in this directory is not an endorsement.